In vitro Anti HSV-1 and HSV-2 Activity of Tanacetum vulgare Extracts and Isolated Compounds: An Approach to their Mechanisms of Action

被引:41
|
作者
Alvarez, Angel L. [1 ]
Habtemariam, Solomon [2 ]
Juan-Badaturuge, Malindra [2 ]
Jackson, Caroline [3 ]
Parra, Francisco [1 ]
机构
[1] Univ Oviedo, Inst Univ Biotecnol Asturias, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain
[2] Univ Greenwich, Pharmacognosy Res Labs, Medway Sch Sci, Chatham ME4 4TB, Kent, England
[3] Hadlow Coll, Tonbridge TN11 0AL, Kent, England
关键词
Tanacetum vulgare; tansy; antiviral; HSV; ethnomedicine; FLAVONOIDS; FLOWERS; HERPES;
D O I
10.1002/ptr.3382
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Herpes simplex viruses (HSV-1 and HSV-2) are responsible for long-term latent infections in humans, with periods of recurring viral replication associated to lesions around the lips, eyes, mucous membrane of the oral cavity or the genitals. The lack of an effective vaccine, the moderate to high toxicity of the available synthetic antiherpes compounds and the appearance of resistant viral strains emphasize the need for new inhibitors. Tanacetum vulgare, commonly known as tansy, has been used for treating rheumatic pain, skin eruption and diuretic conditions as well as an anthelmintic, antihypertensive, stimulant, emmenagogue, carminative, antiseptic, antihypertensive, antispasmodic and antioxidant agent. The anti HSV-1 activity of tansy aerial parts, ethyl acetate extract and the isolated compound parthenolide, has been reported recently. In this work, through a comprehensive mechanistic-based antiherpetic activity study, it was revealed that constituents other than parthenolide are responsible for the antiviral activity of tansy. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:296 / 301
页数:6
相关论文
共 50 条
  • [1] Anti-herpetic Activity ofMacrocystis pyriferaandDurvillaea antarcticaAlgae Extracts Against HSV-1 and HSV-2
    Castillo, Estefania
    Duarte, Luisa F.
    Corrales, Nicolas
    Alvarez, Diana M.
    Farias, Monica A.
    Henriquez, Adolfo
    Smith, Patricio C.
    Agurto-Munoz, Cristian
    Gonzalez, Pablo A.
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [2] Verbascoside isolated from Lepechinia speciosa has inhibitory Activity against HSV-1 and HSV-2 in vitro
    Martins, Fernanda O.
    Esteves, Patricia F.
    Mendes, Gabriella S.
    Barbi, Nanci S.
    Menezes, Fabio S.
    Romanos, Maria T. V.
    NATURAL PRODUCT COMMUNICATIONS, 2009, 4 (12) : 1693 - 1696
  • [3] Seroprevalence of HSV-1 and HSV-2 in Barbados
    Levett, PN
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2005, 194 (1-2) : 105 - 107
  • [4] Seroprevalence of HSV-1 and HSV-2 in Barbados
    P. N. Levett
    Medical Microbiology and Immunology, 2005, 194 : 105 - 107
  • [5] A spiroketal-enol ether derivative from Tanacetum vulgare selectively inhibits HSV-1 and HSV-2 glycoprotein accumulation in Vero cells
    Alvarez, Angel L.
    Habtemariam, Solomon
    Moneim, Ahmed E. Abdel
    Melon, Santiago
    Dalton, Kevin P.
    Parra, Francisco
    ANTIVIRAL RESEARCH, 2015, 119 : 8 - 18
  • [6] RAPID ELECTROPHORETIC DIFFERENTIATION OF HSV-1 AND HSV-2
    PYNDIAH, N
    GLAUSER, L
    DELACUISINE, B
    ANEX, JF
    EXPERIENTIA, 1982, 38 (11): : 1367 - 1367
  • [7] Molecular epidemiology of HSV-1 and HSV-2 in Germany
    Schmidt-Chanasit, J.
    Bialonski, A.
    Heinemann, P.
    Ulrich, R. G.
    Guenther, St.
    Rabenau, H. F.
    Doerr, H. W.
    HAUTARZT, 2010, 61 (02): : 174 - 175
  • [8] Worldwide circulation of HSV-2 × HSV-1 recombinant strains
    David M. Koelle
    Peter Norberg
    Matthew P. Fitzgibbon
    Ronnie M. Russell
    Alex L. Greninger
    Meei-Li Huang
    Larry Stensland
    Lichen Jing
    Amalia S. Magaret
    Kurt Diem
    Stacy Selke
    Hong Xie
    Connie Celum
    Jairam R. Lingappa
    Keith R. Jerome
    Anna Wald
    Christine Johnston
    Scientific Reports, 7
  • [9] Seroprevalence of HSV-1 and HSV-2 infection in the general French population
    Malkin, JE
    Morand, P
    Malvy, D
    Ly, TD
    Chanzy, B
    de Labareyre, C
    El Hasnaoui, A
    Hercberg, S
    SEXUALLY TRANSMITTED INFECTIONS, 2002, 78 (03) : 201 - 203
  • [10] EFFECTS OF PRIOR HSV-1 INFECTION ON GENITAL HSV-2 INFECTION
    BERNSTEIN, DI
    PROGRESS IN MEDICAL VIROLOGY, 1991, 38 : 109 - 127